The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: September 2024

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next

Houlahan, K., E. et al. Science. 384: 6699 (2024).
doi: 10.1126/science.adh8697.

Summary and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

Cancer cells have the ability to hijack various cellular processes and hence despite presenting similar clinical characteristics tumours may present molecular differences with serious implications for disease prognostic and treatment response. The germline genome is highly variable, with differences across individuals occurring at millions of polymorphic sites. This variability may play a role in dictating the somatic evolution of the tumour. Mounting evidence suggests that a subset of T cells may respond to germline-derived epitopes during tumorigenesis.

In this paper, Houlahan et al investigated the role that germline variability may play in the development of various types of breast cancer by mediating immunoediting. Starting from the hypothesis that during tumour progression the body would select against genomic amplifications of germline variants that produce MHC class I antigenic determinants, the authors show that germline-derived epitopes have the ability to influence the molecular subtype that breast tumours commit to. The authors of this paper suggest that this germline-derived epitope burden negative selection is likely to occur beginning from precancerous lesions and persists throughout tumour progression influencing the metastatic predisposition. When tumours develop despite a high germline-derived epitope burden, they develop immune evasion mechanisms and hence tend to be more aggressive.

.

Future impact

Understanding how genome-mediated immunoediting determines the subtype of cancer developed by a patient has important clinical implications as germline variants could potentially be used as blood biomarkers that could identify tumours with high lymphocyte infiltration and could inform the risk of relapse.
.
Read more in Science

4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity

  • 1. Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
  • 2. Characterization of the generic mutant p53-rescue compounds in a broad range of assays
  • 3. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development
  • 4. Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
  • 5. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
  • 6. Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
  • 7. Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
  • 8. Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis
  • 9. Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
  • 10. Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

From Bedside to Bench: Lessons from three award-winning scientists – Episode 30 of The Cancer Researcher Podcast

From Bedside to Bench: Lessons from three award-winning scientists – Episode 30 of The Cancer Researcher Podcast

March 13, 2026

What happens when clinical care directly informs scientific discovery? This episode sees EACR award winners Charlie Swanton, Ayelet Erez and Daniel Kirschenbaum reflect on what drew...

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

Using AI to bridge chemistry, proteomics and precision medicine: Episode 28 of The Cancer Researcher Podcast

January 16, 2026

Our guest in this episode is Bernhard Küster, Professor at the Technical University of Munich, Director of the Bavarian Biomolecular Mass Spectrometry Center and Co-Director of...

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

European cancer research needs renewed urgency, say EACR and EACS leaders in Nature Cancer article

December 10, 2025

René Bernards (EACR Past President) and Johanna Joyce (EACR President Elect), together with Michael Baumann and Anton Berns, have written a new commentary highlighting the urgent...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“Joint efforts can achieve far more than individual work”: Mariacristina Franzese Canonico’s EACR Travel Fellowship
Community

“Joint efforts can achieve far more than individual work”: Mariacristina Franzese Canonico’s EACR Travel Fellowship

April 1, 2026
“The ideal choice to advance my research”: Unai Heras Manterola’s EACR Travel Fellowship
Community

“The ideal choice to advance my research”: Unai Heras Manterola’s EACR Travel Fellowship

April 1, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR